BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11961156)

  • 1. Macrolide-resistant group a streptococcus--now in the United States.
    Huovinen P
    N Engl J Med; 2002 Apr; 346(16):1243-5. PubMed ID: 11961156
    [No Abstract]   [Full Text] [Related]  

  • 2. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
    Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
    Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmid-Borne erm(T) from invasive, macrolide-resistant Streptococcus pyogenes strains.
    Woodbury RL; Klammer KA; Xiong Y; Bailiff T; Glennen A; Bartkus JM; Lynfield R; Van Beneden C; Beall BW;
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1140-3. PubMed ID: 18180360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of mef(A)-containing genetic elements in erythromycin-resistant isolates of Streptococcus pyogenes from Italy.
    D'Ercole S; Petrelli D; Prenna M; Zampaloni C; Catania MR; Ripa S; Vitali LA
    Clin Microbiol Infect; 2005 Nov; 11(11):927-30. PubMed ID: 16216111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Resistance to macrolides in Streptococcus pyogenes].
    Bellido JL; García-Sáenz JA; Manzanares MA; Gutiérrez Zufiaurre MN; García-Rodríguez JA
    Rev Esp Quimioter; 1998 Sep; 11(3):196-204. PubMed ID: 9795305
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapid decrease in the prevalence of macrolide-resistant group A streptococci due to the appearance of two epidemic clones in Cantabria (Spain).
    Oliver MA; García-Delafuente C; Cano ME; Pérez-Hernández F; Martínez-Martínez L; Albertí S
    J Antimicrob Chemother; 2007 Aug; 60(2):450-2. PubMed ID: 17540676
    [No Abstract]   [Full Text] [Related]  

  • 7. Association between resistance to erythromycin and the presence of the fibronectin binding protein F1 gene, prtF1, in Streptococcus pyogenes isolates from German pediatric patients.
    Haller M; Fluegge K; Arri SJ; Adams B; Berner R
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2990-3. PubMed ID: 15980381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythromycin-resistant group A streptococci.
    Linder JA; Stafford RS
    N Engl J Med; 2002 Aug; 347(8):614-5; author reply 614-5. PubMed ID: 12192025
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythromycin-resistant group A streptococci.
    Shulman ST; Tanz R; Kabat W
    N Engl J Med; 2002 Aug; 347(8):614-5; author reply 614-5. PubMed ID: 12195586
    [No Abstract]   [Full Text] [Related]  

  • 10. [Erythromycin resistance of group A beta-hemolytic streptococci isolated from patients with upper respiratory tract infections].
    Yazgi H; Ertek M; Aktaş AE
    Mikrobiyol Bul; 2002 Jan; 36(1):11-4. PubMed ID: 12476761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease of erythromycin resistance in group A streptococci by change of emm distribution.
    Koh EH; Kim S; Lee NY
    Jpn J Infect Dis; 2008 Jul; 61(4):261-3. PubMed ID: 18653965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
    Gattringer R; Sauermann R; Lagler H; Stich K; Buxbaum A; Graninger W; Georgopoulos A
    Int J Antimicrob Agents; 2004 Sep; 24(3):290-3. PubMed ID: 15325435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.
    Uh Y; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2716-8. PubMed ID: 15215133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low macrolide resistance in Streptococcus pyogenes in Southern Argentina.
    Rubinstein G; Amoroso AM; Bavdaz B; De Bunder S; Blazquez N; Gutkind GO
    Int J Antimicrob Agents; 2005 May; 25(5):450-2. PubMed ID: 15848305
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infections.
    Ikebe T; Hirasawa K; Suzuki R; Isobe J; Tanaka D; Katsukawa C; Kawahara R; Tomita M; Ogata K; Endoh M; Okuno R; Watanabe H
    Antimicrob Agents Chemother; 2005 Feb; 49(2):788-90. PubMed ID: 15673769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and microbiological evaluation of miocamycin activity against group A beta-haemolytic streptococci in pediatric patients. Three years' incidence of erythromycin-resistant group A streptococci.
    Borzani M; Varotto F; Garlaschi L; Conio F; Dell'Olio M; Careddu P
    J Chemother; 1989 Jul; 1(4 Suppl):392-4. PubMed ID: 16312455
    [No Abstract]   [Full Text] [Related]  

  • 17. [Streptococcus pyogenes and resistance to macrolides: experience at Monza].
    Minerva Pediatr; 1998; 50(1-2):XII-XIII. PubMed ID: 9658791
    [No Abstract]   [Full Text] [Related]  

  • 18. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh.
    Martin JM; Green M; Barbadora KA; Wald ER
    N Engl J Med; 2002 Apr; 346(16):1200-6. PubMed ID: 11961148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrolide-resistant Streptococcus pyogenes in Central Greece: prevalence; mechanism and molecular identification.
    Malli E; Tatsidou E; Damani A; Pantelidi K; Petinaki E; Skoulakis C; Drougka E; Spiliopoulou I
    Int J Antimicrob Agents; 2010 Jun; 35(6):614-5. PubMed ID: 20206477
    [No Abstract]   [Full Text] [Related]  

  • 20. Clonal relationships among isolates of erythromycin-resistant Streptococcus pyogenes of different geographical origin.
    Kataja J; Huovinen P; Efstratiou A; Pérez-Trallero E; Seppälä H;
    Eur J Clin Microbiol Infect Dis; 2002 Aug; 21(8):589-95. PubMed ID: 12226689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.